{"ok":true,"data":[{"type":"bse_announcement","source":"bse_filing","text":"Announcement under Regulation 30 (LODR)-Acquisition","date":"2026-09-24"},{"type":"bse_announcement","source":"bse_filing","text":"Board Meeting Outcome for Outcome Of Board Meeting Dated September 24, 2026","date":"2026-09-24"},{"type":"bse_announcement","source":"bse_filing","text":"Closure of Trading Window","date":"2026-09-25"},{"type":"bse_announcement","source":"bse_filing","text":"Board Meeting Intimation for The Quarter And Half Year Ending On September 30, 2026","date":"2026-09-25"},{"type":"nse_announcement","source":"regulatory","text":"Dr. Lal Path Labs Ltd. has informed the Exchange about acquisition of 70% stake in SN Genelab Private Limited ( S N Gene ) from its existing Shareholders. Post acquisition, S N Gene shall become a Subsidiary of the Company","date":"2026-09-25"},{"type":"nse_announcement","source":"regulatory","text":"Dr. Lal Path Labs Ltd. has informed the Exchange regarding Outcome of Board Meeting held on September 24, 2026.","date":"2026-09-25"},{"type":"bse_announcement","source":"bse_filing","text":"Announcement under Regulation 30 (LODR)-Updates on Acquisition","date":"2026-09-26"},{"type":"nse_announcement","source":"regulatory","text":"Dr. Lal Path Labs Ltd. has informed the Exchange about General Updates - Update on acquisition-SHL","date":"2026-09-26"},{"type":"nse_announcement","source":"regulatory","text":"Dr. Lal Path Labs Ltd. has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","date":"2026-09-26"},{"type":"bse_announcement","source":"bse_filing","text":"Announcement under Regulation 30 (LODR)-Updates on Acquisition","date":"2026-10-01"},{"type":"nse_announcement","source":"regulatory","text":"Dr. Lal Path Labs Ltd. has informed the Exchange about General Updates","date":"2026-10-02"}]}